CGTLimited DatastaleJuno Therapeutics, a Subsidiary…Phase 2
lisocabtagene maraleucel (JCAR017, JCAR017 (lisocabtagene maraleucel))
Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Small Lymphocytic · Leukemia, Lymphocytic, Chronic, B-Cell
#LeukemiaLymphocyticChronicB-Cell#CGT#Phase2#cell-gene-therapy#CAR-T+5
Trials 34Status Recruiting